Investor Presentaiton
INDIAN
SCENARIO
Indian healthcare sector is expected to
cross US$ 372 billion by 2022.
Indian pharmaceutical industry accounts
for about 3.6% of the global pharmaceu-
tical industry by value.
60% of the world's vaccines are manu-
factured in India.
Every 3rd pill sold in USA is produced by
an Indian generics manufacturer.
The sector is expected to reach US$ 50
billion by 2025.
The sector attracted more than US$ 2
billion in FDI inflows in last 3 years.
MARKET SIZE OF INDIAN
PHARMACEUTICAL SECTOR
(US$ BILLION)
CAGR: 6.41%
33
28.53 29.77
27.57
24.52
22.46
20.95
50
FY11 FY12 FY13 FY14 FY15 FY16 FY17 2025F
Sources: https://www.ibef.org/industry/pharmaceutical-india.aspx
Source: IBEF Research, Department of Commerce,
Department of Pharmaceuticals, India Business News, BMIView entire presentation